Neurofibrillary tangles composed of hyperphosphorylated fibrillized tau are found in numerous tauopathies including Alzheimer's disease. Increasing evidence suggests that tau pathology can be transmitted from cell-to-cell; however the mechanisms involved in the initiation of tau fibrillization and spreading of disease linked to progression of tau pathology are poorly understood. We show here that intracerebral injections of preformed synthetic tau fibrils into the hippocampus or frontal cortex of young tau transgenic mice expressing mutant human P301L tau induces tau hyperphosphorylation and aggregation around the site of injection, as well as a time-dependent propagation of tau pathology to interconnected brain areas distant from the injection site. Furthermore, we show that the tau pathology as a consequence of injection of tau preformed fibrils into the hippocampus induces selective loss of CA1 neurons. Together, our data confirm previous studies on the seeded induction and the spreading of tau pathology in a different tau transgenic mouse model and reveals neuronal loss associated with seeded tau pathology in tau transgenic mouse brain. These results further validate the utility of the tau seeding model in studying disease transmission, and provide a more complete in vivo tauopathy model with associated neurodegeneration which can be used to investigate the mechanisms involved in tau aggregation and spreading, as well as aid in the search for disease modifying treatments for Alzheimer's disease and related tauopathies.
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Introduction
An important hallmark of Alzheimer's disease (AD) is the accumulation of insoluble hyperphosphorylated and fibrillized tau in neurofibrillary tangles (NFTs) (reviewed by Ballatore et al., 2007) . Since there is a clear correlation between NFT density and cognitive decline, misfolded and aggregated tau is likely a key pathological agent in AD (Arriagada et al., 1992; Gómez-Isla et al., 1997) . The hypothesis that tau plays a critical role in AD pathogenesis was further strengthened by the discovery that inherited forms of frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17) resulted from mutations within the tau gene (Goedert, 2005a; Goedert and Jakes, 2005b) . This provided evidence that alterations of tau itself can directly lead to neurodegenerative disease and suggested that tau aggregation in the AD brain could, indeed, be involved in disease onset and progression.
The events leading to tau aggregate formation are not completely understood and were long thought to be entirely cell-autonomous, with protein misfolding occurring independently in many cells. Recent studies have shown, however, that prion-like cell-to-cell spreading mechanisms might be important in the propagation of tau pathology. In AD, tau inclusions occur in a particular brain area and progress in a well-defined predictable manner (Braak and Braak, 1991; Braak et al., 2011) 
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